Propyl Thiouracil Market - Forecast(2021 - 2026)

Report Code: HCR 16518 Report Format: PDF + Excel (Delivery in 48 Hrs)

Propyl Thiouracil Market Overview

Propyl Thiouracil Market size is estimated to reach $3,000 million by 2026, growing at a CAGR of 10% over 2021-2026. Propylthiouracil are also called propranolol and is considered as an oral medication for the treatment of hyperthyroidism and also treat people with Graves ’ disease which acts by hampering the thyroid gland from producing excess thyroid hormone. Propylthiouracil is a medication that binds to thyroid peroxidase inhibitor for the conversion of iodide to iodine. Propylthiouracil is administered orally whose initial doses for adults is 300 mg daily and for pediatric patients doses is 50mg. Thiamazole are also called methimazole that reverses hyperthyroidism more quickly than propylthiouracil. Carbimazole are preferred antithyroid medicines than propylthiouracil owing to rising risk of hepatotoxicity with propylthiouracil. Growing prevalence of thyroid gland disorders and rising advanced infrastructure are the major factor driving the growth of this market. Furthermore, increasing research and development activities is set to further enhance the overall market demand for Propyl Thiouracil Market for the period 2021-2026.

Propyl Thiouracil Market Report Coverage

The report: “Propyl Thiouracil Market Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Propyl Thiouracil Market.   

By Type: Thyroperoxidase Inhibitor, 5-Deiodinase Inhibitor, and Others
By End-Use Industry: Hospitals, Clinics, and Others
By Geography: North America (U.S., Canada, Mexico), Europe (U.K, Germany, Italy, France, Spain, Russia, Rest of Europe), Asia Pacific (China, Australia, Japan, South Korea, India, Rest of Asia Pacific), South America (Brazil, Argentina, Others) and Rest of the World (Middle East, Africa).

Key Takeaways

Geographically, in 2020, North America dominated the Propyl Thiouracil Market owing to increasing prevalence of thyroid gland disorders and increasing development in health infrastructure.
Growing prevalence of thyroid gland disorders and rising advanced infrastructure are likely to aid in the market growth of the Propyl Thiouracil. 
Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Propyl Thiouracil Market report.  
Increasing side effects is set to create hurdles for the Propyl Thiouracil Market. 

Propyl Thiouracil Market Segment Analysis – By Type

The global Propyl Thiouracil Market based on Type can be further segmented into Thyroperoxidase Inhibitor, 5-Deiodinase Inhibitor, and Others. The Thyroperoxidase Inhibitor segment is the major segment generating revenue in 2020. This is owing to increasing uses of propyl inhibitor for the treatment of Thyroperoxidase Inhibitor increases the demand of this segment. The 5-Deiodinase Inhibitor segment is estimated to register the fastest CAGR of 5.8% for the period 2021-2026. This is owing to it is used for the synthesis of the active form of thyroid hormone that increases the use of propranolol and are increasing the growth of this segment.

Propyl Thiouracil Market Size, By Type 2020-2026 (USD Million)

 

Propyl Thiouracil Market Segment Analysis – By Application

The global Propyl Thiouracil Market based on Application can be further segmented into, Hospitals, Clinics, and Others. The Hospitals segment registers for the Propyl Thiouracil highest market share in 2020. This is mainly owing to increasing availability of medicine, proper treatment and availability of skilled professional and increasing treatment of skin reaction owing to propylthiouracil tablets increases the demand of treatment in hospitals and are increasing the growth of this segment. The Clinics segment is estimated to register the fastest CAGR of 4.2% over 2021-2026. This is mainly owing to availability of 24 hours services for the treatment that produces excess thyroid gland are increasing the growth of this market.

Propyl Thiouracil Market Segment Analysis – By  Geography

North America dominated the Propyl Thiouracil Market with major share of 40% in 2020. This is owing to increasing prevalence of thyroid gland disorders and increasing development in health infrastructure. According to American Thyroid Association, about 20 million Americans in 2020 have thyroid diseases that increases the treatment of thyroid disorder owing to hyperthyroidism and are rising the growth of this market. However, Asia-Pacific is estimated to outpace all the regions by clocking the highest CAGR of 15% during the forecast period 2021-2026 owing to rising geriatric population and increasing development in healthcare facilities. 

Propyl Thiouracil Market Drivers

Growing Prevalence of Thyroid Gland Disorders

Increasing prevalence of Thyroid Gland disorders and increasing demand for hyperthyroidism treatments increases the growth of the Propyl Thiouracil Market. Moreover, Increasing awareness regarding the health issue owing to thyroid gland are increasing the growth of the Propyl Thiouracil Market over 2021-2026. 

Rising Advanced Infrastructure

Increasing advancement in the treatment of thyroid gland and rising advancement in technology is increasing the growth of the Propyl Thiouracil Market. Moreover, various treatment such as Carbimazole and Thiamazole are used for the treatment of excessive thyroid gland that increases the growth of Propyl Thyroid Market over 2021-2026.  

Covid Impact: 
COVID-19 pandemic had greatly affected the Propyl Thiouracil Market. Patients with thyroid disease are treating with medication known as methimazole that sometimes decreases the number of immune cells that fight infection and can cause fever and sign of illness which overlap with the symptoms of COVID-19 infection and create problems with the people suffering from thyroid disorder that are negatively affected the growth of this market.

Propyl Thiouracil Market Challenge

Increasing Side Effects

The factors that is set to impede the growth of the Propyl Thiouracil Market are the increasing side effects such as hair loss, muscle pain, nausea, dizziness, sleepiness, swelling, nerve pain is set to create hurdles for the Propyl Thiouracil Market. 

Propyl Thiouracil Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Propyl Thiouracil Market. Propyl Thiouracil top 10 companies include, Shanghai Worldyang Chemical Co., Limited, Yc Biotech (Jiangsu) Co., Ltd, Xi'an Prius Biological Engineering Co., Ltd., Lupin, Jiangsu Cidic Import & Export Co., Ltd., Hangzhou Royall Import & Export Co., Ltd, Hefei Joye Import & Export Co., Ltd., Shaanxi TOP Pharm Chemical Co., Ltd., Baoji Guokang Bio-Technology Co., Ltd. and Lubon Industry Co., Ltd.

Acquisitions/Product Launches

In November 2019, Lupin receives sANDA approval for Levothyroxine Sodium Tablets that are used for the treatment of hypothyroidism.

Relevant Reports:

Report Code: HCR 58284

Report Code: HCR 0398

For more Lifesciences and Healthcare Market reports, please click here

1. Propyl Thiouracil Market Overview
    1.1 Definitions and Scope
2. Propyl Thiouracil Market Executive Summary
    2.1 Market Size and Key Trends
    2.2 Key trends by Type
    2.3 Key trends by End-Use Industry
    2.4 Key trends by Geography
3. Propyl Thiouracil Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Propyl Thiouracil Market - Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Propyl Thiouracil Market - Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Propyl Thiouracil Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes
7. Propyl Thiouracil Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Propyl Thiouracil Market – By Type (Market Size -$Million/$Billion)
    8.1 Thyroperoxidase Inhibitor,
    8.2 5-Deiodinase Inhibitor
    8.3 Others
9. Propyl Thiouracil Market – By End-Use Industry (Market Size -$Million/$Billion)
    9.1 Hospital
    9.2 Clinics
    9.3 Others
10. Propyl Thiouracil Market - By Geography (Market Size -$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Canada
        10.1.3 Mexico
    10.2 South America
        10.2.1 Brazil
        10.2.2 Argentina
        10.2.3 Others
    10.3 Europe
        10.3.1 U.K.
        10.3.2 Germany
        10.3.3 Italy
        10.3.4 France
        10.3.5 Spain
        10.3.6 Russia
        10.3.7 Rest of Europe
    10.4 Asia-Pacific
        10.4.1 China
        10.4.2 Australia
        10.4.3 Japan
        10.4.4 South Korea
        10.4.5 India
        10.4.6 Rest of Asia-Pacific
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. Propyl Thiouracil Market Entropy
12. Propyl Thiouracil Market - Industry / Segment Competition landscape Premium Premium
    12.1 Market Share Analysis
        12.1.1 Market Share by Country- Key companies
        12.1.2 Market Share by Region- Key companies
        12.1.3 Market Share at Global Level- Key companies
        12.1.4 Best Practices for Companies
13. Propyl Thiouracil Market - Key Company List by Country Premium Premium
14. Propyl Thiouracil Market Company Analysis
    14.1 Company Revenue, Products, M&A, Developments
    14.2 Company 1
    14.3 Company 2
    14.4 Company 3
    14.5 Company 4
    14.6 Company 5
    14.7 Company 6
    14.8 Company 7
    14.9 Company 8
    14.10 Company 9
    14.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global GLOBAL PROPYL THIOURACIL MARKET, BY MECHANISM OF ACTION Market 2019-2024 ($M)
1.1 THYROPEROXIDASE INHIBITOR Market 2019-2024 ($M) - Global Industry Research
1.2 5- DEIODINASE INHIBITOR Market 2019-2024 ($M) - Global Industry Research
2.Global GLOBAL PROPYL THIOURACIL MARKET, BY MECHANISM OF ACTION Market 2019-2024 (Volume/Units)
2.1 THYROPEROXIDASE INHIBITOR Market 2019-2024 (Volume/Units) - Global Industry Research
2.2 5- DEIODINASE INHIBITOR Market 2019-2024 (Volume/Units) - Global Industry Research
3.North America GLOBAL PROPYL THIOURACIL MARKET, BY MECHANISM OF ACTION Market 2019-2024 ($M)
3.1 THYROPEROXIDASE INHIBITOR Market 2019-2024 ($M) - Regional Industry Research
3.2 5- DEIODINASE INHIBITOR Market 2019-2024 ($M) - Regional Industry Research
4.South America GLOBAL PROPYL THIOURACIL MARKET, BY MECHANISM OF ACTION Market 2019-2024 ($M)
4.1 THYROPEROXIDASE INHIBITOR Market 2019-2024 ($M) - Regional Industry Research
4.2 5- DEIODINASE INHIBITOR Market 2019-2024 ($M) - Regional Industry Research
5.Europe GLOBAL PROPYL THIOURACIL MARKET, BY MECHANISM OF ACTION Market 2019-2024 ($M)
5.1 THYROPEROXIDASE INHIBITOR Market 2019-2024 ($M) - Regional Industry Research
5.2 5- DEIODINASE INHIBITOR Market 2019-2024 ($M) - Regional Industry Research
6.APAC GLOBAL PROPYL THIOURACIL MARKET, BY MECHANISM OF ACTION Market 2019-2024 ($M)
6.1 THYROPEROXIDASE INHIBITOR Market 2019-2024 ($M) - Regional Industry Research
6.2 5- DEIODINASE INHIBITOR Market 2019-2024 ($M) - Regional Industry Research
7.MENA GLOBAL PROPYL THIOURACIL MARKET, BY MECHANISM OF ACTION Market 2019-2024 ($M)
7.1 THYROPEROXIDASE INHIBITOR Market 2019-2024 ($M) - Regional Industry Research
7.2 5- DEIODINASE INHIBITOR Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Propyl Thiouracil Market Revenue, 2019-2024 ($M)
2.Canada Propyl Thiouracil Market Revenue, 2019-2024 ($M)
3.Mexico Propyl Thiouracil Market Revenue, 2019-2024 ($M)
4.Brazil Propyl Thiouracil Market Revenue, 2019-2024 ($M)
5.Argentina Propyl Thiouracil Market Revenue, 2019-2024 ($M)
6.Peru Propyl Thiouracil Market Revenue, 2019-2024 ($M)
7.Colombia Propyl Thiouracil Market Revenue, 2019-2024 ($M)
8.Chile Propyl Thiouracil Market Revenue, 2019-2024 ($M)
9.Rest of South America Propyl Thiouracil Market Revenue, 2019-2024 ($M)
10.UK Propyl Thiouracil Market Revenue, 2019-2024 ($M)
11.Germany Propyl Thiouracil Market Revenue, 2019-2024 ($M)
12.France Propyl Thiouracil Market Revenue, 2019-2024 ($M)
13.Italy Propyl Thiouracil Market Revenue, 2019-2024 ($M)
14.Spain Propyl Thiouracil Market Revenue, 2019-2024 ($M)
15.Rest of Europe Propyl Thiouracil Market Revenue, 2019-2024 ($M)
16.China Propyl Thiouracil Market Revenue, 2019-2024 ($M)
17.India Propyl Thiouracil Market Revenue, 2019-2024 ($M)
18.Japan Propyl Thiouracil Market Revenue, 2019-2024 ($M)
19.South Korea Propyl Thiouracil Market Revenue, 2019-2024 ($M)
20.South Africa Propyl Thiouracil Market Revenue, 2019-2024 ($M)
21.North America Propyl Thiouracil By Application
22.South America Propyl Thiouracil By Application
23.Europe Propyl Thiouracil By Application
24.APAC Propyl Thiouracil By Application
25.MENA Propyl Thiouracil By Application
26.SHANGHAI WORLDYANG CHEMICAL CO., LIMITED, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.XI'AN PRIUS BIOLOGICAL ENGINEERING CO., LTD., Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.YC BIOTECH CO., LTD, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.WUHAN VANZ PHARM INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.JIANGSU CIDIC IMPORT EXPORT CO., LTD., Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.HANGZHOU ROYALL IMPORT EXPORT CO., LTD, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.HEFEI JOYE IMPORT EXPORT CO., LTD, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.SHAANXI TOP PHARM CHEMICAL CO., LTD., Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.BAOJI GUOKANG BIO-TECHNOLOGY CO., LTD., Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.LUBON INDUSTRY CO., LTD., Sales /Revenue, 2015-2018 ($Mn/$Bn)